Trial site
The Cognitive and Research Center of New Jersey
- 11running trials
- 4closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease15 trials
- Mild cognitive impairment6 trials
- Frontotemporal dementia1 trial
- Phase
- Phase 39 trials
- Phase 23 trials
- Status
- Active, not recruiting7 trials
- Completed4 trials
- Recruiting3 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Eli Lilly and Company7 trials
- Cognito Therapeutics, Inc.3 trials
- Hoffmann-La Roche2 trials
- Acumen Pharmaceuticals1 trial
- Bristol-Myers Squibb1 trial
- and 1 more
Running trials
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Active, not recruiting
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Recruiting
Recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Enrolling by invitation
Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Active, not recruiting
Multi-Center Study of Sensory Stimulation to Improve Brain Function
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease4 recruiting
- Mild cognitive impairment2 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026